Lataa...
Guillain-Barré syndrome after COVID-19 vaccination
We report a case of Guillain-Barré syndrome (GBS) occurring soon after the first dose of Vaxzevria (previously known as COVID-19 vaccine AstraZeneca). Thus far, there has been no evidence of an increased risk of GBS resulting from either COVID-19 infection nor from COVID-19 vaccines; however, indivi...
Tallennettuna:
| Julkaisussa: | BMJ Case Rep |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2021
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8327820/ https://ncbi.nlm.nih.gov/pubmed/34330729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2021-244125 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|